Umang Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.84 Cr
as on 16-11-2024
- Company Age 32 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.50 M
as on 16-11-2024
- Satisfied Charges ₹ 53.30 Cr
as on 16-11-2024
- Revenue -44.03%
(FY 2023)
- Profit -168.71%
(FY 2023)
- Ebitda -156.11%
(FY 2023)
- Net Worth -33.31%
(FY 2023)
- Total Assets -32.55%
(FY 2023)
About Umang Pharmatech
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 2.84 Cr.
The company currently has active open charges totaling ₹0.50 M. The company has closed loans amounting to ₹53.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Renu Budhraja, Umang Budhraja, and Payal Budhraja serve as directors at the Company.
- CIN/LLPIN
U29297MH1992PTC066815
- Company No.
066815
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Umang Pharmatech Pvt Ltd offer?
Umang Pharmatech Pvt Ltd offers a wide range of products and services, including Glass, Gem Stone, Wood & Other Beads, Beads, Pharmaceutical Machinery & Equipment, Pharmaceutical Dryers, Corporate and Soft Skills Training, Corporate Training, Dryers & Evaporators, Dryers, Packaging Films & Foils, Plastic Film.
Who are the key members and board of directors at Umang Pharmatech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umang Budhraja  | Director | 20-Jan-2020 | Current |
| Renu Budhraja | Director | 18-May-1992 | Current |
Payal Budhraja  | Director | 11-Mar-2023 | Current |
Financial Performance of Umang Pharmatech.
Umang Pharmatech Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.03% decrease. The company also saw a substantial fall in profitability, with a 168.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 33.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Umang Pharmatech?
In 2023, Umang Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Labultima Process Technologies Private LimitedActive 8 years 11 monthsUmang Budhraja is a mutual person
- Umang Encapsulation Solutions Private LimitedActive 3 years 9 months
Umang Budhraja is a mutual person
- Excipient Granules And Ingredients Private LimitedActive 1 year 22 days
Umang Budhraja is a mutual person
Charges (Loans)
₹0.05 Cr
₹53.30 Cr
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2000 | Syndicate Bank | ₹0.50 M | Open |
| 28 Apr 2021 | Axis Bank Limited | ₹4.40 Cr | Satisfied |
| 28 Jun 2018 | Others | ₹11.26 Cr | Satisfied |
| 03 Oct 2016 | Others | ₹13.00 Cr | Satisfied |
| 13 Mar 2012 | The Bassein Catholic Co-Op Bank Limited | ₹7.50 M | Satisfied |
How Many Employees Work at Umang Pharmatech?
Umang Pharmatech has a workforce of 46 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Umang Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umang Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
